Guidelines for the diagnosis and management of adult aplastic anaemia.
about
Eltrombopag for the treatment of aplastic anemia: current perspectivesFrom chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.Molecular alterations in the TCR signaling pathway in patients with aplastic anemia.Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia.Incidence and outcome of acquired aplastic anemia-real-world data from patients diagnosed in Sweden from 2000-2011.Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review.Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasmPredictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study.Circulating microRNAs: promising biomarkers in aplastic anemia.Aplastic anemia: the correct nomenclature matters.Lessons learned from a review of paroxysmal nocturnal haemoglobinuria (PNH) requests: a report from the UK PNH Network.Diagnosis and Treatment of Aplastic Anemia.Hypomegakaryocytic thrombocytopenia and increased number of PNH-phenotype cells - an emerging subgroup of myelodysplastic syndrome showing frequent response to immunosuppression - RESPONSE to Rafferty & Leach.Efficacy of antithymocyte globulin as first-line treatment for aplastic anemia-a single-center experience.British Committee for Standards in Haematology guidelines for aplastic anaemia: single centre retrospective review finds no compelling evidence for the recommended higher platelet count threshold of 20 × 10(9) /l.Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting.First-line choice for severe aplastic anemia in children: Transplantation from a haploidentical donor vs immunosuppressive therapy.Paediatric amendment to adult BSH Guidelines for aplastic anaemia.Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia.Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in severe aplastic anemia patients: A cohort study.A composite mouse model of aplastic anemia complicated with iron overload.Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China.Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia.Aplastic anemia during pregnancy: a review of obstetric and anesthetic considerations.Concurrent treatment of aplastic anemia/Paroxysmal Nocturnal Hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience.British Committee for Standards in Haematology guidelines for aplastic anemia: Single centre retrospective review finds no compelling evidence for the recommended higher platelet count threshold of 20 × 10(9) /L - RESPONSE to Yan et al.The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia.Are mild/moderate acquired idiopathic aplastic anaemia and low-risk myelodysplastic syndrome one or two diseases or both and how should it/they be treated?Short-term efficacy and safety of antithymocyte globulin treatment in elderly patients with acquired aplastic anaemia.Anorexia nervosa-associated pancytopenia mimicking idiopathic aplastic anemia: a case report.Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload.Value of transfusion independence in severe aplastic anemia from patients' perspectives - a discrete choice experiment(teleomorph ) candidaemia in a patient with aplastic anaemia: a case reportComparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disordersHeterozygous variants in bone marrow failure and myeloid neoplasmsFrequent mutations in CD8 T cells from patients with pure red cell aplasiaAltered Expression of Hematopoiesis Regulatory Molecules in Lipopolysaccharide-Induced Bone Marrow Mesenchymal Stem Cells of Patients with Aplastic Anemia
P2860
Q28071710-858D7A70-1A54-4E6F-B3C3-28413A6ED4B1Q33441627-2F1D1B65-52FF-40ED-A5B1-9BBFAF740C54Q36758322-A5A80B1E-2D32-4412-B323-356808ED0BABQ37265484-8C3F10C7-AC66-4DA8-AE73-9784817F36B4Q37597265-683580ED-EBB6-45A4-A54E-BD62A8EE7361Q37730037-42D40E4B-E2B9-4F94-8F58-85CD1A758A08Q38656500-77C2E81D-0501-4C6A-B37B-AEB441A8D165Q39269167-C1E5933F-EB1B-4BEC-B92D-B91F9FFEFBD0Q39289359-69B65ADB-9D88-4E96-93AA-55C9C040D416Q40090645-6C862D2A-81F8-4FBB-9952-D0D8AE68D584Q40678281-8EE2F7A4-8A88-45FD-8F00-FD9543AA5914Q42334374-C9ECD853-7CBE-4F8C-A5C6-1DB6323672DEQ42384342-B7877C05-D220-46A9-9A0F-A90FF036DD09Q47718431-7ECF5EA0-9B3A-46EA-A5E8-92B84A8B29A4Q47836932-8797F134-2AF6-486B-88C0-B6D3327CB234Q47869897-160979C9-8094-4E7E-BDAD-85AE8E9C13B0Q48106657-854B4ABA-203F-46D9-BAE3-C7F3CCF38CDEQ48176279-12CA720C-3907-4F3F-9748-EBB028B66602Q48305083-90D6BBFE-C50C-4E7C-98BA-9A0ED97BF812Q48317044-FC90BDC0-6D6A-44BF-AEBC-85B7442646FBQ48333946-0AA117B1-641B-4366-A7B9-AB8745705623Q48537627-3384711E-E73C-4785-A87B-DE20960633B2Q50053950-C2EB1CA4-AB7A-4353-A7FF-F3CE46CF5451Q50054152-6C23D69B-FD90-498D-8B5F-D2AA3323A2D2Q50057440-FD3DF75A-DD5F-4E1B-872D-313A936F0E71Q51017260-C3B8BDE8-1501-4809-8F78-6311CB108494Q52356888-90A115F8-AE90-4594-B96C-BD21DFD25AFBQ52802804-B9275E53-5183-413B-94F2-083C1C4405E1Q52809640-1468450B-FA6F-4A93-8A92-874D990F23B4Q53809669-00F80BFB-E5BF-4036-B1D4-9DC221E90E5CQ54043084-FF84D1E7-BF0C-4469-B91B-0A05244A275AQ54544762-ABEDD9A3-8E10-4DAD-B41E-1E53F03D0558Q55284335-FE197EF2-DD93-4405-AD06-7ECE1899DC61Q55365418-917907E5-1BAB-4E2F-A8D3-FA8D6F1BD3C8Q56764372-6F430BAF-7E88-401E-AC0A-0585F90D5DDEQ57496227-C8CE1EF7-29FF-4A31-94A3-0775CF0AED2DQ57689300-EA55775F-628B-4409-8D88-6B49C7C8871DQ57754008-6508A80B-A2AD-46C9-80D4-B9C46E92A479Q57795871-F95E6CD4-25BB-4F57-A328-E23148E583B0Q58699520-8E6A1E4E-F465-4838-AA84-D5F223F94302
P2860
Guidelines for the diagnosis and management of adult aplastic anaemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Guidelines for the diagnosis and management of adult aplastic anaemia.
@en
Guidelines for the diagnosis and management of adult aplastic anaemia.
@en-gb
type
label
Guidelines for the diagnosis and management of adult aplastic anaemia.
@en
Guidelines for the diagnosis and management of adult aplastic anaemia.
@en-gb
prefLabel
Guidelines for the diagnosis and management of adult aplastic anaemia.
@en
Guidelines for the diagnosis and management of adult aplastic anaemia.
@en-gb
P2093
P356
P1476
Guidelines for the diagnosis and management of adult aplastic anaemia.
@en
P2093
Anita Hill
Austin Kulasekararaj
British Society for Standards in Haematology
Ghulam Mufti
Inderjeet Dokal
Jamie Cavenagh
John A Snowden
Judith C W Marsh
P304
P356
10.1111/BJH.13853
P407
P577
2015-11-16T00:00:00Z